DK0888379T3 - Forbindelser tilhørende amidinium-familien, farmaceutiske præparater indeholdende disse forbindelser og anvendelsen deraf - Google Patents

Forbindelser tilhørende amidinium-familien, farmaceutiske præparater indeholdende disse forbindelser og anvendelsen deraf

Info

Publication number
DK0888379T3
DK0888379T3 DK97907154T DK97907154T DK0888379T3 DK 0888379 T3 DK0888379 T3 DK 0888379T3 DK 97907154 T DK97907154 T DK 97907154T DK 97907154 T DK97907154 T DK 97907154T DK 0888379 T3 DK0888379 T3 DK 0888379T3
Authority
DK
Denmark
Prior art keywords
compounds
amidinium
family
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK97907154T
Other languages
Danish (da)
English (en)
Inventor
Jean-Marie Lehn
Pierre Lehn
Jean-Pierre Vigneron
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0888379(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9602604A external-priority patent/FR2745569B1/fr
Priority claimed from FR9609557A external-priority patent/FR2751972B1/fr
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of DK0888379T3 publication Critical patent/DK0888379T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97907154T 1996-03-01 1997-02-28 Forbindelser tilhørende amidinium-familien, farmaceutiske præparater indeholdende disse forbindelser og anvendelsen deraf DK0888379T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9602604A FR2745569B1 (fr) 1996-03-01 1996-03-01 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications
FR9609557A FR2751972B1 (fr) 1996-07-30 1996-07-30 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications
PCT/FR1997/000364 WO1997031935A1 (fr) 1996-03-01 1997-02-28 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications

Publications (1)

Publication Number Publication Date
DK0888379T3 true DK0888379T3 (da) 2001-01-29

Family

ID=26232562

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97907154T DK0888379T3 (da) 1996-03-01 1997-02-28 Forbindelser tilhørende amidinium-familien, farmaceutiske præparater indeholdende disse forbindelser og anvendelsen deraf

Country Status (18)

Country Link
US (2) US6143729A (enExample)
EP (1) EP0888379B1 (enExample)
JP (1) JP4271260B2 (enExample)
KR (1) KR19990087372A (enExample)
AT (1) ATE198599T1 (enExample)
AU (1) AU723998B2 (enExample)
BR (1) BRPI9707889B8 (enExample)
CZ (1) CZ295225B6 (enExample)
DE (1) DE69703878T2 (enExample)
DK (1) DK0888379T3 (enExample)
ES (1) ES2154453T3 (enExample)
GR (1) GR3035205T3 (enExample)
HU (1) HU228072B1 (enExample)
IL (1) IL125926A (enExample)
NO (1) NO311806B1 (enExample)
PT (1) PT888379E (enExample)
SK (1) SK283575B6 (enExample)
WO (1) WO1997031935A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884430B1 (en) * 1997-02-10 2005-04-26 Aventis Pharma S.A. Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
FR2763943B1 (fr) * 1997-05-28 1999-07-09 Rhone Poulenc Rorer Sa Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
FR2777017B1 (fr) * 1998-04-02 2002-08-23 Rhone Poulenc Rorer Sa Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications
KR20010042318A (ko) * 1998-04-02 2001-05-25 아방티 파르마 소시에테 아노님 신규 핵산 전달제, 이를 함유하는 조성물 및 용도
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
FR2824557B1 (fr) * 2001-05-14 2003-08-29 Aventis Pharma Sa Derives lipidiques de polythiouree
JP4276439B2 (ja) * 2001-05-14 2009-06-10 サントリオン ポリチオ尿素の脂質誘導体
FR2829136B1 (fr) 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
EP1479985B1 (en) 2002-01-17 2017-06-14 Alfa Laval Corporate AB Submerged evaporator comprising a plate heat exchanger and a cylindric casing where the plate heat exchanger is arranged
JP4980893B2 (ja) * 2005-04-28 2012-07-18 日本曹達株式会社 新規なグアニジン化合物、製造方法及びそれらを含有する殺菌性組成物
EP2069500B1 (en) * 2006-10-04 2014-09-24 Centre National De La Recherche Scientifique (Cnrs) Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof
EP2350296A4 (en) * 2008-11-17 2013-04-03 Enzon Pharmaceuticals Inc BRANCHED CATIONIC LIPIDS FOR THE SYSTEM FOR INTRODUCING NUCLEIC ACIDS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
KR960705771A (ko) * 1993-11-24 1996-11-08 벤자민 에프 맥그로우 구아니딘의 양쪽친화성 유도체(amphiphilic derivatives of guanidine)
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5811406A (en) * 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes

Also Published As

Publication number Publication date
PT888379E (pt) 2001-05-31
SK118298A3 (en) 1999-02-11
JP2000506136A (ja) 2000-05-23
NO311806B1 (no) 2002-01-28
EP0888379B1 (fr) 2001-01-10
ES2154453T3 (es) 2001-04-01
AU1930497A (en) 1997-09-16
GR3035205T3 (en) 2001-04-30
DE69703878T2 (de) 2001-04-26
AU723998B2 (en) 2000-09-07
BR9707889A (pt) 2000-01-04
CZ295225B6 (cs) 2005-06-15
CZ277298A3 (cs) 1998-12-16
NO983691D0 (no) 1998-08-12
ATE198599T1 (de) 2001-01-15
JP4271260B2 (ja) 2009-06-03
HUP9902465A1 (hu) 1999-12-28
IL125926A0 (en) 1999-04-11
EP0888379A1 (fr) 1999-01-07
SK283575B6 (sk) 2003-09-11
DE69703878D1 (de) 2001-02-15
US6316422B1 (en) 2001-11-13
WO1997031935A1 (fr) 1997-09-04
HU228072B1 (en) 2012-09-28
IL125926A (en) 2004-09-27
KR19990087372A (ko) 1999-12-27
NO983691L (no) 1998-08-12
BR9707889B1 (pt) 2010-03-23
KR100452062B1 (enExample) 2005-04-08
BRPI9707889B8 (pt) 2016-11-08
US6143729A (en) 2000-11-07
HUP9902465A3 (en) 2009-10-28

Similar Documents

Publication Publication Date Title
DE69729583D1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-on derivative als faktor xa inhibitoren
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
DK41193D0 (da) Ionkanalaabnere
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
BG103485A (en) Ketobanzamides as calpain inhibitors
NO971415D0 (no) Aminoheterocykliske derivater som anti-trombose- eller antikoagulantmidler
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
TR199701427T1 (xx) �nsektisidler olarak kullan�lan bisiklik aminler.
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
ATE241998T1 (de) Multikatalytische protease-inhibitoren
DE69127690D1 (de) Antiatherosklerotische und antithrombotische 1-benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on-derivate
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
YU89691A (sh) Postupak za dobijanje stereoselektivnih derivata fenilizoserina
NO983691D0 (no) Forbindelser tilhörende amidiniumfamilien, farmasöytiske preparater inneholdende disse samt anvendelse derav
TR200001010T2 (tr) Ürokinaz önleyicileri olan izokinolinler.
DE69526917D1 (de) Anthracyclinon-derivate und ihre verwendung in amyloidose
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
NO981393D0 (no) Guanidinoproteasehemmere
DK0714387T3 (da) Hidtil ukendte bis-naphthalimider til behandling af cancer
TR199701298T1 (xx) Tetralinler.
ATE247955T1 (de) Selenophen-antitumormittel
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.
DE59107500D1 (de) Neue Beta-Galactosidase-Substrate für den CEDIA
TWI263639B (en) Novel tetrazole derivative